GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synairgen PLC (OTCPK:SYGGF) » Definitions » Operating Cash Flow per Share

SYGGF (Synairgen) Operating Cash Flow per Share : $-0.04 (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Synairgen Operating Cash Flow per Share?

Synairgen's operating cash flow per share for the six months ended in Jun. 2024 was $-0.02. Synairgen's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.04.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 36.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Synairgen's Operating Cash Flow per Share or its related term are showing as below:

SYGGF' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -196.2   Med: 3.2   Max: 36.7
Current: 36.7

During the past 13 years, Synairgen's highest 3-Year average Operating Cash Flow per Share Growth Rate was 36.70% per year. The lowest was -196.20% per year. And the median was 3.20% per year.

SYGGF's 3-Year OCF Growth Rate is ranked better than
84.51% of 1194 companies
in the Biotechnology industry
Industry Median: 3.6 vs SYGGF: 36.70

Synairgen Operating Cash Flow per Share Historical Data

The historical data trend for Synairgen's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synairgen Operating Cash Flow per Share Chart

Synairgen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.22 -0.27 -0.09 -0.05

Synairgen Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 0.01 -0.03 -0.02 -0.02

Competitive Comparison of Synairgen's Operating Cash Flow per Share

For the Biotechnology subindustry, Synairgen's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synairgen's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synairgen's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Synairgen's Price-to-Operating-Cash-Flow falls into.


Synairgen Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Synairgen's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=-10.405/201.375
=-0.05

Synairgen's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )=Cash Flow from Operations (Q: Jun. 2024 )/Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
=-4.693/201.375
=-0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synairgen Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Synairgen's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Synairgen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synairgen PLC (OTCPK:SYGGF) » Definitions » Operating Cash Flow per Share
Comparable Companies
LSE:CIZ LSE:IXI LSE:APTA LSE:IMM LSE:OPTI LSE:GENF LSE:ROQ LSE:FAB LSE:OBD LSE:BSFA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
SNG:UK OMY:Germany
Address
Southampton General Hospital, Tremona Road, Mailpoint 810, Level F, South Block, Southampton, GBR, SO16 6YD
Website
https://www.synairgen.com
Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.